{"id":767517,"title":"Canadian vaccine safety surveillance reports following immunization - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-04","captureTimestamp":"2026-03-04T20:35:39.476000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-1-2-january-february-2024/canadian-vaccine-safety-surveillance-reports-following-immunization.html","snippet":"Canadian vaccine safety surveillance reports following immunization Download this article as a PDF (809 KB) Published by: The Public Health Agency of Canada Issue: Volume 50-1/2, January/February 2024: Respiratory Syncytial Virus (RSV) Date published: January/Fabruary 2024 ISSN:…","rawSnapshotUrl":"/api/snapshots/raw/767517","browseUrl":"https://replay.healtharchive.ca/job-7/20260304203539/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2024-50/issue-1-2-january-february-2024/canadian-vaccine-safety-surveillance-reports-following-immunization.html#ha_snapshot=767517","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}